Replimune Common Stock Net 2018-2025 | REPL

Replimune common stock net from 2018 to 2025. Common stock net can be defined as the value of common equity ownership.

Replimune Common Stock Net 2018-2025 | REPL

Replimune common stock net from 2018 to 2025. Common stock net can be defined as the value of common equity ownership.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$231.3B
Amgen (AMGN)$153.3B
Gilead Sciences (GILD)$137.2B
Vertex Pharmaceuticals (VRTX)$96.3B
Bristol Myers Squibb (BMY)$92.3B
CSL (CSLLY)$83.7B
GSK (GSK)$76.6B
Regeneron Pharmaceuticals (REGN)$60.4B
Alnylam Pharmaceuticals (ALNY)$57B
Argenex SE (ARGX)$41.1B
BioNTech SE (BNTX)$26.8B
Royalty Pharma (RPRX)$20.8B
Insmed (INSM)$20.7B
Biogen (BIIB)$18.7B
Incyte (INCY)$15.3B
Illumina (ILMN)$14.7B
Genmab (GMAB)$14.6B
Genmab (GNMSF)$14.3B
Ascendis Pharma (ASND)$11.6B
BioMarin Pharmaceutical (BMRN)$11.4B
QIAGEN (QGEN)$10.7B
Swedish Orphan Biovitrum (BIOVF)$10.6B
Moderna (MRNA)$10.4B
Exelixis (EXEL)$10.1B
Verona Pharma American Depositary Share (VRNA)$9B
Blueprint Medicines (BPMC)$8.3B
Exact Sciences (EXAS)$8.2B
Bio-Techne Corp (TECH)$7.9B
Roivant Sciences (ROIV)$7.9B
Halozyme Therapeutics (HALO)$7.7B